HBK Sorce Advisory Portfolio holdings
Top Buys
| 1 |
VCRM
Vanguard Core Tax-Exempt Bond ETF
VCRM
|
+$237M |
| 2 |
Vanguard Core Bond ETF
VCRB
|
+$138M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$47.8M |
| 4 |
Vanguard Growth ETF
VUG
|
+$33.6M |
| 5 |
Booking.com
BKNG
|
+$17.4M |
Top Sells
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$23.9M |
| 2 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$8.86M |
| 3 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
+$2.21M |
| 4 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$1.34M |
| 5 |
Apple
AAPL
|
+$938K |
Sector Composition
| 1 | Technology | 5.88% |
| 2 | Financials | 2.77% |
| 3 | Industrials | 1.93% |
| 4 | Communication Services | 1.82% |
| 5 | Healthcare | 1.66% |
Similar funds
HBK Sorce Advisory's Q1 2026 Portfolio in Review
As of Q1 2026, HBK Sorce Advisory held 704 positions worth $5.05B, up 16% from $4.35B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
HBK Sorce Advisory deployed $490M of net new capital in Q1 2026, opening 76 new positions and adding to 317 existing holdings. Its largest new stake was AstraZeneca: 4,017 shares worth $735K.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 5.9% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $23.9M trimmed.
- HBK Sorce Advisory's largest Q1 2026 buy was AstraZeneca: 4,017 shares worth $735K.
- HBK Sorce Advisory added most to Vanguard Core Tax-Exempt Bond ETF in Q1 2026, an estimated $237M increase.
- HBK Sorce Advisory's biggest Q1 2026 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $23.9M.
- HBK Sorce Advisory fully exited iShares National Muni Bond ETF in Q1 2026, selling an estimated $817K.
- HBK Sorce Advisory's ten largest holdings make up 70% of its $5.05B portfolio in Q1 2026.
- HBK Sorce Advisory opened 76 new positions and closed 40 in Q1 2026.
- HBK Sorce Advisory's portfolio value rose 16% quarter-over-quarter to $5.05B.
Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.